Complaint
| Product Name | Sonwu Supply Pharmaceutical Raw Material Olaparid |
| CAS NO. | 763113-22-0 |
| MF | C24h23fn4o3 |
| MW | 434.46 |
| Density | 1.43 |
| Appearance | White Powder |
| Certificate | ISO, SGS, GMP, HACCP |
| Assay Method | HPLC |
| Extraction Type | Solvent Extraction |
| Sample | Available |
| MOQ | 5g |
| Shelf life | 2 Years |
| Storage | Store in cool & dry place not freeze Keep away from strong light and heat |
Olaparib is a new oral polyadenosine diphosphate ribose polymerase [PARP] inhibitor. PARP includes the most important members of three protein families: PChemicalbookARP1, PARP2 and PARP3. PARP enzymes are involved in normal cellular homeostasis such as DNA transcription, cell cycle regulation and DNA repair.
Olaparib is a potent poly(ADP-ribose) polymerase (PARP) inhibitor. Olaparib has been shown to induce significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo. Recent studies show that Olaparib increases radiosensitivity of a lung tumor xenograft, making it a potential candidate for use in combination with radiotherapy.
| Other Hot-Selling Similar Products | ||||
| Capecitabine | Everolimus | Afatinib | Vandetanib | Gefitinib |
| Temozolomid | Rapamycin | Axitinib | Sorafenib tosylate | Cediranib |
| Cabozantinib | Selumetinib | Crizotinib | Sunitinib malate | Erlotinib |
| Crizotinib | Lapatinib | Debrafenib | Cabazitaxel | Ponatinib |
